Physician profile
Vandana K Patel
NPI 1821037524
$104,718.59
in general payments reported to CMS, 2019-2025
46 companies · $83K in 2025
The $83K reported for 2025 was more than what 97% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $1,718 · 2021: $2,800 · 2022: $2,252 · 2023: $4,497 · 2024: $8,838 · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Food and Beverage: $16K · Travel and Lodging: $13K · Consulting Fee: $6,884 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,680.00 |
| Food and Beverage | $16,067.25 |
| Travel and Lodging | $12,631.84 |
| Consulting Fee | $6,884.34 |
| Education | $110.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $69,412.10 | 2025 | Neffy |
| Ionis Pharmaceuticals, INC. | $6,781.82 | 2025 | Dawnzera |
| Regeneron Pharmaceuticals, INC. | $4,695.95 | 2023-2025 | Dupixent |
| Genzyme Corporation | $2,936.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $2,824.55 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $2,128.32 | 2019-2025 | Dupixent |
| Csl Behring | $1,649.63 | 2019-2025 | Hizentra, Haegarda, Andembry |
| Blueprint Medicines Corporation | $1,527.88 | 2020-2024 | Ayvakit |
| Sanofi US Services INC. | $1,462.97 | 2025 | |
| Glaxosmithkline, LLC. | $1,362.84 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $1,283.30 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,249.35 | 2021-2025 | Hyqvia, Cuvitru, Takhzyro |
| Biocryst US Sales Co., LLC | $1,165.24 | 2022-2025 | Orladeyo |
| Pfizer INC. | $867.34 | 2019-2025 | |
| Amgen INC. | $617.93 | 2021-2025 | Tezspire, Actimmune |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $615.20 | 2019-2023 | Odactra, Ragwitek, Grastek |
| Pharming Healthcare, INC. | $591.86 | 2022-2025 | Ruconest, Joenja |
| Kaleo, INC. | $446.55 | 2019-2024 | Auvi-Q |
| Grifols USA, LLC | $360.20 | 2019-2025 | Xembify, Prolastin-C Liquid |
| Horizon Therapeutics Plc | $262.91 | 2022-2023 | Actimmune |
| Genentech USA, INC. | $235.09 | 2019-2024 | Xolair |
| Leo Pharma INC. | $218.19 | 2022-2023 | Adbry |
| Adma Biomanufacturing LLC | $207.52 | 2024-2025 | |
| Covis Pharma Gmbh | $191.51 | 2021-2022 | |
| Octapharma USA, INC. | $162.04 | 2021-2025 | Panzyga, Cutaquig |
| Incyte Corporation | $130.15 | 2022-2025 | Opzelura |
| Aquestive Therapeutics, INC. | $119.22 | 2025 | |
| Abbvie INC. | $118.40 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $116.41 | 2019-2022 | |
| Circassia INC. | $114.35 | 2019-2024 | Niox |
| Hikma Pharmaceuticals USA | $112.95 | 2023-2025 | Ryaltris |
| Paragon 28, INC. | $111.38 | 2025 | Apex 3d |
| Genentech, INC. | $107.19 | 2023-2024 | Xolair |
| Optinose US, INC. | $101.06 | 2021-2025 | |
| Galderma Laboratories, L.P. | $72.57 | 2025 | Nemluvio |
| Aytu Biopharma, INC. | $62.85 | 2021-2025 | Karbinal |
| Greer Laboratories, INC. | $56.48 | 2025 | Oralair |
| Merck Sharp & Dohme LLC | $46.56 | 2021-2023 | |
| Gc Biopharma USA, INC. | $39.51 | 2024-2025 | Alyglo, Alyglo |
| Mylan Specialty L.P. | $31.92 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.00 | 2021 | |
| Gilead Sciences, INC. | $25.93 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.91 | 2025 | Immulite 1000 Immunoassay System |
| Phadia US INC. | $16.50 | 2021 | |
| Organon LLC | $16.02 | 2025 | Vtama |
| Aimmune Therapeutics, INC. | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vandana Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.